India's First Integrated Digital Accelerator

Aptimmune

Aptimmune is a biotechnology company that specializes on developing mucosal vaccines for swine.

Status

Independent

Sectors

Employees

Founders

Federico Zuckermann, Heather Bessoff

Last Funding

8/7/2018

Listed/Private

Private

Funding Stage

Size

Founded

January 1, 2010

Investors

The Yield Lab, Cultivation Capital, Kemin Industries, Arsenal Capital Partners, Fox Ventures

Acquisitions

Ticker

NA

Study your competition to stay ahead

Found Something Useful?

LOGIN TO CONTINUE

OR

GET COMPLETE ACCESS BY BECOMING A MEMBER.

IT'S FREE!

This website uses cookies to ensure you get the best experience on our website.